ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares

This study has been completed.

Sponsored by: University Hospital, Ghent
Information provided by: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00228332
  Purpose

A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares


Condition Intervention Phase
Verrucae Vulgares
Drug: Administration of zinkgluconaat or placebo
Phase II

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study
Official Title:   A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Disappearence of the verrucae vulgares after 3 months

Estimated Enrollment:   70
Study Start Date:   April 2004
Study Completion Date:   March 2006

Detailed Description:

A Double-blind, placebo-controlled trial investigating the effect of a treatment with zinkgluconaat for verrucae vulgares

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Patients with verrucae vulgares

Exclusion Criteria:

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00228332

Locations
Belgium
University Hospital Ghent    
      Ghent, Belgium, 9000

Sponsors and Collaborators
University Hospital, Ghent

Investigators
Principal Investigator:     Annelies Stockman, MD     University Hospital, Ghent    
  More Information


Website University Hospital Ghent  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   2004/005
First Received:   September 13, 2005
Last Updated:   December 19, 2007
ClinicalTrials.gov Identifier:   NCT00228332
Health Authority:   Belgium: Institutional Review Board

Study placed in the following topic categories:
Virus Diseases
Skin Diseases, Infectious
Warts
Skin Diseases
DNA Virus Infections
Papillomavirus Infections

Additional relevant MeSH terms:
Skin Diseases, Viral
Neoplasms
Tumor Virus Infections

ClinicalTrials.gov processed this record on October 10, 2008




Links to all studies - primarily for crawlers